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Guidelines for the use of diagnostic imaging in musculoskeletal (MSK) pain conditions 





Musculoskeletal (MSK) pain is one of the most common reasons for primary care 
consultation, particularly pain in the lower back (LBP), knee, and shoulder. The use of 
diagnostic imaging for musculoskeletal pain is increasing but it is unclear whether this 




To identify and map the content of CPGs that inform the use of diagnostic imaging in those 
with non-traumatic LBP, knee, and shoulder pain in primary and intermediate care in the UK.  
 
Design and Setting 
 




This scoping review was conducted and is reported in accordance with PRISMA guidance. A 
broad search strategy included electronic searches of MEDLINE, CINAHL, PsychINFO and 
SPORTDiscus from 2009 to the 17th April 2019. This was conducted alongside a search of 
 
 
guideline repositories and was combined with a snowball search of Google, relevant 




31 relevant CPGs were included. Routine use of diagnostic imaging for those with non-
traumatic LBP, knee or shoulder pain is generally discouraged in primary care or 
intermediate care. Diagnostic imaging should be reserved for when specific or serious 
pathology is suspected or where the person is not responding to initial non-surgical 




Diagnostic imaging should not be routinely requested in primary or intermediate care for 
non-traumatic LBP, knee, or shoulder pain.  CPGs do not justify the increasing imaging rates 
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Musculoskeletal (MSK) pain conditions are one of the most common reasons for primary care 
consultation (Jordan et al., 2010), with the highest prevalence for low back, shoulder and knee 
pain (Urwin et al., 1998; Jordan et al., 2010). The majority of these presentations are non-
traumatic and often cannot be attributed to a specific structural or biomedical diagnosis. In 
turn, these are regularly allocated a non-specific label (Jordan et al., 2010).  
 
For nearly all of those presenting with lower back pain (LBP), knee or shoulder pain the 
recommended first-line clinical care is non-surgical (Lin et al., 2019) and includes advice and 
education, exercise, activity modification, and pharmacological interventions. More invasive 
treatments such as injections or surgery are reserved for a smaller proportion of patients with 
either clear pathology that justifies a particular type of invasive intervention or for patients 
whose symptoms persist following recommended non-surgical treatment (Lin et al., 2019). 
Whilst this ‘stepped care’ approach is advocated, the indications for proceeding to surgery in 
those that have not previously responded to non-surgical management have been challenged 
(Lurie et al., 2015; Beard et al., 2018; Sihvonen et al., 2018). 
 
The decision to request diagnostic imaging (DI) is increasing in early primary care 
consultations. Between 2014-2019, there has been a 16% increase in the use of radiology 
within the National Health Service (NHS). This level of demand has been acknowledged as a 
challenge within the NHS (NHS England, 2019b). A recent systematic review (SR) and 
meta-analysis investigated global rates of imaging for LBP over the ten-year interval from 
1995 to 2015. This review estimated that 24.8% of patients with LBP that present to primary 
care currently will undergo DI and found that the rate of complex imaging (MRI and CT 
Scan) has increased by 50% for those consulting in primary care or emergency departments 
(Downie et al., 2019). Despite this increase in investigation rate, for those presenting with 
acute or sub-acute LBP in primary care, no difference is seen between those who received 
 
 
imaging and those who received usual care without imaging (Chou et al., 2009) with regards 
to pain, function or quality of life at any time point up to 12-months (Chou et al., 2009). 
Similar findings have been demonstrated for knee pain (Karel et al., 2015) and shoulder pain 
(Bradley, Tung and Green, 2005).   
In the context of a rising prevalence of imaging, the problems associated with the risk of 
misuse of DI are well recognised. These include a potential waste of finite healthcare 
resources, poorer perceived prognosis and an increased chance of undergoing surgery 
(Webster et al., 2014; Darlow et al., 2017). Furthermore, there is considerable uncertainty 
about how scan findings, for example ultrasound scan (USS) evidence of a rotator cuff tear 
(Girish et al., 2011), or evidence of a prolapsed intervertebral disc on an MRI scan (Brinjikji 
et al., 2015) correlate with patient symptoms. Despite this uncertainty and questionable 
added value, scan results are perceived by patients as authoritative (Cuff and Littlewood, 
2018). Given that a substantial proportion of primary care consultations involve MSK pain 
presentations and 90% of all consultations occur within primary care (Network, 2019), there 
is a clear need to better understand the reasons for the increasing use of DI.  
Clinical practice guidelines (CPGs) are ‘statements that include recommendations intended 
to optimise patient care that are informed by a systematic review of evidence and an 
assessment of the benefits and harms of alternative care options’ (Graham, Mancher and 
Miller Wolman, 2011). They are a key source of information about the appropriate use of DI 
(Darlow et al., 2017). The aim of this study was to identify, summarise, and identify 
similarities and differences between CPGs that inform UK clinical practice with respect to DI 








This scoping review was designed with reference to guidance described by the Joanna 
Briggs Institute (Peters, et al. 2015). An attempt was made to register the protocol with 
PROSPERO however, scoping review protocols are not currently accepted. Any deviations 
from the protocol are outlined below.  
Eligibility Criteria 
CPGs were included which: 
• were either developed in the UK or intended for wider regional use that inform MSK 
clinical practice within UK primary or intermediate care. 
• met the definition of a CPG: statements that include recommendations intended to 
optimise patient care that are informed by a systematic review of evidence and an 
assessment of the benefits and harms of alternative care options. 
• provide recommendations on the use of DI in adults with non-traumatic LBP, knee, 
and shoulder pain. 
• were published between 2009-2019 and accessible in the public domain. 
Search Strategy & Information Sources 
The full electronic search strategy can be found in Supplementary Tables 1-22. 
A comprehensive search of key databases (MEDLINE, CINAHL complete, PsycINFO and 
SPORTDiscus) was undertaken from 2009 to the 17th April 2019. The full MEDLINE search 
strategy for LBP can be found in Table 1. This was complemented by a search of CPG 
repositories as well as a ‘snowball’ search of the top 50 results from a Google search and 
the websites of professional bodies relevant to primary care MSK practice. A request for 
CPGs that met the inclusion criteria was circulated through the same professional bodies as 
well as through the social media platform Twitter. 
Insert Table 1 here 
 
 
Selection of Sources of Evidence  
All titles identified were screened by one reviewer (AC) and duplicates removed using 
Mendeley reference management software following a pilot of the selection criteria and 
process by authors AC and RT. 
Following this initial screening, if abstracts were available, they were reviewed independently 
by two reviewers (AC and RT) who applied the selection criteria. Where a decision could not 
be made on eligibility, or if an abstract for the CPG was not available, the full CPG document 
was obtained.  
Full CPG documents were reviewed independently by two reviewers (AC and RT) and if it 
was not clear whether the identified document met the criteria for definition as a CPG, then 
the producing organisation (or authors if there was no producing organisation identified) 
were contacted for further information. In cases of no response to the request for further 
information and following reminders, the document was excluded. 
Finally, the reference list of all selected CPGs was hand searched by one reviewer (AC).  
Data charting process 
The relevant characteristics of the included CPGs and the key data items relevant to the 
review objectives were recorded in a charting table. 
Data extraction was first tested, independently, by two reviewers (AC and RT) using five 
included CPGs. Changes were agreed upon by both reviewers and implemented including 
the removal of the columns titled ‘development process’ and ‘concept e.g. imaging modality’.  
One reviewer (AC) was responsible for charting the results and these were verified by a 





Critical appraisal of individual sources of evidence  
An assessment of the rigour of the development process was performed through a 
modification of the Appraisal of Guidelines for Research and Evaluation (AGREE) II tool. All 
included CPGs were appraised using the third domain of the AGREE II tool ‘Rigour of 
Development’; the AGREE II tool does not provide cut-off scores for whether a CPG is high 
or low quality however, previous reviews have utilised this domain as an important indicator 
of CPG quality. If a CPG scored ≥50% then the CPG was deemed high quality (Lin et al., 
2018).  
Synthesis of results 
When all results were charted, a narrative synthesis was undertaken to provide an overview 
of recommendations. A narrative synthesis refers to the process of combining, outlining, and 
summarising the recommendations via a textual approach (Popay et al., 2006). Through this 





















Selection of sources of evidence 
A total of 12,775 citations were identified through the search strategies. Following the study 
selection process, 31 CPGs met the inclusion criteria (Table 2). 26 citations were excluded 
at full document stage and the reasons for exclusion are outlined in brief within Figure 1. 
Insert Figure 1 here 
Insert Table 2 here 
 
CPG Origin 
The majority of included CPGs were developed in the UK (n = 19), followed by development 
as part of a continental (European) workforce (n = 9) and international workforce 
development (n = 3). 
Regional MSK Pain Presentations 
The included CPGs were equally divided between those for a specific MSK pain 
presentation (n = 16) with LBP (n=5), knee (n=8) and shoulder pain (n=3) and those for a 
regional pain condition that has the potential to present as LBP, knee or shoulder pain (n = 
15). 
CPG Rigour of Development 
The majority (27/31) of the included CPGs were deemed to be of high quality; the common 
areas of guideline development lacking rigour were balancing the benefits of 
recommendations alongside risks, harms or side effects; undergoing an external 
consultation period for stakeholder input and providing clarity on any intended updates 




Recommendations on the use of diagnostic imaging in those with LBP, knee and 
shoulder pain. 
The majority (21/31) of the included CPGs made recommendations on the use of DI within 
primary and intermediate care (Supplementary Tables S23-26). 
Synthesis of Results 
Low Back Pain (CKS, 2013, 2018a, 2018c; White et al., 2014; Mandl et al., 2015; Ward et 
al., 2016; Compston et al., 2017; McVeigh et al., 2017; Remedios et al., 2017; Ralston et al., 
2019) 
Routine DI is not recommended within primary care or intermediate care, in either non-
specialist (e.g. GP Practice) or specialist (e.g. Musculoskeletal Interface Clinic) settings. In 
the absence of suspected serious pathology, imaging is not recommended within non-
specialist settings but rather should be reserved for cases in whom serious pathology is 
suspected. Within a specialist setting, DI should be reserved for cases for whom it is likely to 
change clinical management decisions. 
The use of x-ray is discouraged in those with LBP unless a fracture or axial 
spondyloarthropathy (SpA) is suspected. Where there is a suspicion of axial SpA, if 
sacroiliitis is not demonstrated and suspicion remains, the recommendation is to perform an 
MRI of the sacroiliac joints. The National Institute for Health and Care Excellence (NICE) 
SpA guidelines (McVeigh et al., 2017) also recommend the addition of a Whole Spine MRI 
however, the European League Against Rheumatism (EULAR) guidelines (Mandl et al., 
2015) do not recommend this.  
Knee Pain (W Zhang et al., 2010; Colebatch et al., 2013; Fernandes et al., 2013; McAlindon 
et al., 2014; Conaghan et al., 2014; Barton et al., 2015; Hajioff et al., 2015; Mandl et al., 
2015; Crossley et al., 2016; CKS, 2017a; McVeigh et al., 2017; Price et al., 2017; Remedios 




The majority of CPGs relevant to knee pain focus on knee osteoarthritis (OA); those CPGs 
for patellofemoral pain (PFP) make no recommendations on the use of DI. Knee OA is 
typically considered a clinical diagnosis based on age ≥45 years, activity related joint pain 
and absence of significant morning stiffness. Routine imaging is not recommended for 
patients with suspected knee OA or during follow up of those with known OA.  
The recommendations are to consider the use of DI to exclude alternative presentations in 
atypical presentations, such as suspected gout or if there is a sudden clinical deterioration. 
In such circumstances an x-ray is recommended as the initial investigation. If peripheral SpA 
or malignancy are suspected, then it is recommended to consider an USS and/or MRI. 
Shoulder Pain (Hanchard et al., 2011; Colebatch et al., 2013; Conaghan et al., 2014; 
Dejaco et al., 2015; Hajioff et al., 2015; CKS, 2017b, 2018b; McVeigh et al., 2017; Remedios 
et al., 2017; Richette et al., 2019; Ralston et al., 2019) 
Routine imaging is not recommended for those with shoulder pain. If movement is 
significantly restricted, symptoms are not improving or if suspecting serious pathology then a 
two-view x-ray is recommended. USS and MRI are usually not recommended for those with 
shoulder pain unless gout or malignancy are suspected. 
Similarities between CPGs 
The recommendations of the CPGs included are similar. The routine use of DI for those with 
non-traumatic LBP, knee or shoulder pain is discouraged. In clinical circumstances where 
serious pathology is suspected, or where the person is not responding to initial conservative 
management and the imaging result is expected to change management decisions, then DI 
is indicated. 
Differences between CPGs 
The differences are concerned with modality and clinical setting. The use of x-ray in those 
with LBP is discouraged unless there is a clinical suspicion of a specific pathology, for 
 
 
example spinal fracture. In those with knee or shoulder pain, an x-ray is encouraged as the 
initial investigation. 
The recommendations within the guidelines are sometimes written with the care setting in 
mind, e.g. what should be considered within primary care (Price et al., 2017); whilst others 
are written with the level of expertise in mind e.g. specialist settings (Ward et al., 2016) as 







The aim of this scoping review was to identify and map the content of CPGs relevant to UK 
clinical practice in primary and intermediate care, specifically regarding the use of DI for 
adults with non-traumatic LBP, knee, and shoulder pain. To date, this represents the most 
up to date and comprehensive review of CPGs and recommendations regarding DI within 
these care settings for these musculoskeletal pain presentations. The routine use of DI for 
those with non-traumatic LBP, knee or shoulder pain is discouraged across CPGs. DI should 
be reserved for where serious pathology is suspected, the person is not responding to initial 
conservative management or the imaging result is expected to change management 
decisions. 
 
The CPGs for LBP consistently recommend against the use of x-ray unless there is a 
suspicion of specific pathology. This differs to the CPGs for knee or shoulder pain where the 
use of x-ray as a first line investigation, albeit for a minority of cases, is recommended. A 
possible reason for this may be that x-ray findings of peripheral joints may alter the 
management plan to a greater extent than in the spine. A spinal fracture is usually managed 
for pain-relief in the absence of neurological signs with surgical options being limited 
(McCarthy and Davis, 2016). In contrast, in peripheral joints an x-ray may inform the 
decision to refer for orthopaedic opinion for consideration of more invasive intervention such 
as arthroplasty.  
 
Strengths and limitations 
To date, this represents the most up to date and comprehensive review of CPGs and 
recommendations for use of diagnostic imaging within UK primary and intermediate care 
 
 
settings. The strengths of this scoping review include conduct in accordance with good 
practice as recommended for the conduct of scoping reviews (Peters et al., 2015) and the 
methods have been reported clearly, allowing for replication. Previous scoping reviews 
(Lowe et al., 2018) have demonstrated how the use of novel social media can complement a 
search strategy to increase the reach and totality of a search. Using Twitter impressions can 
act as a measure of reach within those using Twitter as a means of Continuing Professional 
Development (CPD). Within the 14-days that the tweet involved within the search strategy 
was live, the analytics demonstrate that it was retweeted by 73 people and that 21,375 
twitter uses saw the tweet. The inclusion of the tweet as part of the search strategy identified 
8 additional hits that were not identified from the more traditional means of searching, two of 
which were included within the review. This further demonstrates that the inclusion of twitter 
within a search strategy offers a pragmatic, accessible and low-cost method of increasing 
the reach and totality of a search.  
The results of this scoping review must be considered with respect to its limitations. The 
inclusion criteria for this review were strict in respect that only CPGs were reviewed, and 
only those citations that satisfied the definition of a CPG were included. This means that 
resources that clinicians may use to guide their clinical practice, including those that may be 
described as a ‘guideline’ without satisfying the criteria for a CPG, may have been excluded. 
The focus of this review was also limited to UK practice which limits the generalisation of the 
findings however, it must be considered that the findings are similar to a review of 
international guidelines (Lin et al., 2019). 
Comparison with existing literature 
The results of this scoping review are similar to the findings of a recent SR of high-quality 
international CPGs (Lin et al., 2019). This SR aimed to identify recommendations that were 
common across a wide range of MSK pain conditions, derived from CPGs. With regards to 
investigations, it was recommended that DI was discouraged unless serious pathology is 
suspected; there has been unsatisfactory response to conservative care or unexplained 
 
 
progression of signs and symptoms; it is likely to change management. Within this review by 
Lin et al. (2019), recommendations did not focus on a particular care setting or country of 
practice and excluded specific diseases processes e.g. rheumatological conditions. The 
inclusion of regional MSK conditions within this scoping review that may present as LBP, 
knee or shoulder pain adds to the knowledge base as it highlights a level of consistency with 
regard to recommendations for the use of DI across clinical populations.  
 
Implications for research and practice 
This review included 31 CPGs that were published between 2009 and 2019. 26 hits returned 
by the search were excluded with 18 either due to not fulfilling the definition or criteria of a 
CPG (n=12) or being unable to determine whether the definition or criteria had been fulfilled 
(n=6). In most circumstances, this related to the absence of an initial systematic review 
being undertaken as part of the CPG development process. 
 
The NICE accreditation programme appraises the processes used to develop a CPG with 
the aim of raising CPG development standards, ensuring high-quality processes are utilised, 
high-quality information disseminated to clinicians and in turn to increase the chances that 
the guideline is used to improve patient outcomes. The presence of the accreditation award 
is intended to identify the most trusted sources of CPGs that have been developed (NICE 
2019). Of note was the exclusion of Kulkarni et al. (2015) which had associated NICE 
accreditation (Kulkarni et al., 2015). The reason for exclusion was due to the systematic 
review upon which the CPG was supposed to be based had bring undertaken in 2009, and 
seemingly independent of the CPG process. Therefore, whilst this means that the publication 
does not meet the definition of a CPG and is excluded from the review, the wider implication 




This raises two issues; the first questioning the utility of the NICE accreditation programme 
as a mark of quality and the second that this publication provides a substantial amount of the 
information upon which the NICE CKS for shoulder pain (Excellence, 2017) is based, which 
has been included within this scoping review. In turn, it not clear whether the 
recommendations made within the CKS are founded on the best available, contemporary 
evidence which may impact on clinical decisions and subsequent patient outcomes.  
 
The recommendations within the CPGs varied regarding presentation, either by care setting 
or by level of expertise. Historically, primary care was considered a non-specialist setting in 
which an initial assessment would be undertaken and the patient referred to a specialist 
setting (if needed) in secondary care. In recent years, this approach to patient pathway 
design has changed with specialist services increasingly delivered in primary and community 
care settings in the UK, a change further reinforced within the NHS Long Term Plan (NHS 
England, 2019a). Future CPGs should consider this within the development process to aid 
implementation of recommendations into contemporary practice.  
 
With the routine use of DI discouraged, it would appear that CPGs do not justify the 
increasing imaging rates in the UK for musculoskeletal pain. This would suggest that other 
factors such as clinician behaviour, or patient expectations may offer a more likely 









The routine use of DI for those with non-traumatic LBP, knee or shoulder pain is discouraged 
in primary and intermediate care. DI within a primary care or intermediate care setting within 
UK practice should be reserved for cases where specific or serious pathology is suspected 
or where the person is not responding to initial non-surgical management and the imaging 
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Table 1. Search terms – LBP (Medline) 
1. (in title/abstract) 
MH “Practice Guidelines”) 
2. (in title/abstract) OR 
Guideline* OR consensus OR recommendations 
3. (title/abstract) AND 
Lumb* or LBP or NSLBP or CNLSBP or non-specific or low* or back or spin* or 
radic* or stenosis or facet* or inf* or fracture or scoliosis or cancer* or malign* or 
cord or cauda or CES or spond* or OA or osteo* 
4. (title/abstract) AND 
Imaging or diagnostic imaging or x-ray or radiograp* or ultraso* or USS or MRI or 
magnetic resonance imaging or computed tomography or radiolog* or CT 
Limits: 2009 – to date of search, English Language, Guidelines, Consensus 
Development Conference, Practice Guideline 
 
 
Table 2: This table provides an overview of CPGs included within the scoping review.  
 






Ward et al. 
(Ward et al., 
2016)  
2016 National Institute for 
Health and Care 
Excellence (NICE) 





(CKS) – LBP 
(CKS, 
2018a) 
2018 NICE LBP UK 50% 
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2014 NICE LBP UK 78.6% 
Zhang et al. 
(Weiya 
Zhang et al., 
2010) 
2010 EULAR Knee Pain Europe 57.1% 
Price et al. 
(Price et al., 
2017)  
2017 British Orthopaedic 
Association (BOA) 
Knee Pain UK 26.7% 
Sakellariou 
et al. (G. 
Sakellariou 
et al., 2017) 




et al., 2013) 
2017 EULAR Knee Pain Europe 57.1% 
Crossley et 
al. (Crossley 
et al., 2016) 
2016 Patellofemoral Pain 
Research Retreat 
Knee Pain International 53.5% 
Barton et al. 
(Barton et 
al., 2015)  

















2011 Chartered Society of 
Physiotherapy (CSP) 
Shoulder Pain Frozen 
Shoulder 
71.4% 











et al., 2017) 
2017 National Osteoporosis 
Guideline Group  
Osteoporosis UK 62.5% 
Ralston et 
al. (Ralston 
et al., 2015) 
2015 Scottish International 
Guidelines Network 
(SIGN) 
Osteoporosis UK 66% 
Lems et al. 
(Lems et al., 
2017) 
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McVeigh et 
al. (McVeigh 
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2017 NICE Spondyloarthropathy 
(SpA) 
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Mandl et al. 
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Hui et al. 
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2017 The Royal College of 
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CPG, Clinical Practice Guideline; CKS, Clinical Knowledge Summary; EULAR, European 
League Against Rheumatism; LBP, Lower back pain; NICE, National Institute for Health and 
Care Excellence; OARSI, Osteoarthritis Research Society International; SIGN, Scottish 







Figure 1. Flowchart outlining the selection process for Clinical Practice Guideline 




























*Where it was not clear whether a systematic review had been conducted as part of the CPG development process (in order to 
meet the definition of a CPG) authors were contacted, if no reply was received, this hit was excluded. 
Number identified through 
systematic search (n= 
12752) Additional hits found from 
parallel strands i.e. Google 
(n =9), Professional Bodies 
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